Image

larger text    
    


 		  
  • About APIC
  • Member Services
  • Education & Certification
  • Research Foundation
  • Guidelines & Standards
  • Public Policy
  • Resources/Information Services
    
 
 
Email this Page
Home > Practice Guidance > ID Center > Anthrax
News  |  Overview  |  Clinical Pathway  |  Resource List  |  Selected Reading

Anthrax

Latest News New on the Site
May 7
VaxGen sells anthrax vaccine to rival firm
Apr 8
DoD funds development of anthrax vaccine patch
Feb 29
Judge dismisses suit to limit DoD anthrax vaccinations
Dec 3
Newspaper says lobbying helped sink anthrax vaccine
Oct 31
GAO critiques anthrax vaccine procurement, management
Oct 16
US funds work on drugs for plague, tularemia, anthrax
Oct 3
Federal grants support new anthrax countermeasures
Sep 26
HHS orders 18 million doses of anthrax vaccine
Sep 14
Inhaled anthrax vaccine is said to work in animals
Sep 10
Animal hides were likely cause of 2 anthrax cases
Aug 14
Student treated after anthrax spill in Mississippi lab
May 30
VaxGen stops work on anthrax vaccine, seeks partner
Apr 25, 2007
HHS offers plan for defense against biological threats
Jan 10, 2007
2001 anthrax attack cast wide shadow
Dec 20, 2006
HHS cancels VaxGen anthrax vaccine contract
Dec 11, 2006
CDC rates hospital bioterrorism preparedness
Nov 6, 2006
FDA orders delay of anthrax vaccine trial
Oct 19, 2006
Pentagon to resume mandatory anthrax shots for some
Aug 10, 2006
Canadian anthrax outbreak grows, felling 746 animals
Jul 31, 2006
HHS adds new anthrax drug to national stockpile
Jul 17, 2006
Anthrax in Canada kills 149 animals, infects man
Jun 20, 2006
HHS to buy 20,000 courses of anthrax antitoxin
May 11, 2006
New anthrax vaccine for US stockpile to be delayed
May 9, 2006
Vaccine may permit shorter antibiotic course for anthrax
May 5, 2006
HHS buys another 5 million doses of anthrax vaccine
Apr 25, 2006
New anthrax antidote performs well in animals
Feb 28, 2006
Tests back hides as anthrax source in New York case
Feb 22, 2006
New York man has first US anthrax case since 2001
    
Conference report on public health and clinical guidelines for anthrax
From Apr Emerg Infect Dis

Detoxified lethal toxin as a potential mucosal vaccine against anthrax
From Apr Clin Vaccine Immunol

Decontamination of fluid milk containing Bacillus spores using commercial household products
From Mar J Food Prot

Anthrax: Current, comprehensive information on pathogenesis, microbiology, epidemiology, diagnosis, treatment, and prophylaxis
CIDRAP-authored overview, updated Mar 9
Treatment of experimental anthrax with recombinant capsule depolymerase
From Mar Antimicrob Agents Chemother

Detection of Bacillus anthracis spore germination in vivo by bioluminescence imaging
From Mar Infect Immun

Serum IgG antibody response to the protective antigen (PA) of Bacillus anthracis induced by anthrax vaccine adsorbed (AVA) among US military personnel
From Feb 13 Vaccine

Inactivation kinetics of avirulent Bacillus anthracis spores in milk with a combination of heat and hydrogen peroxide
From Feb J Food Prot

Rat survival to anthrax lethal toxin is controlled by a single gene
From Feb Pharmacogenomics J

Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses
From Jan 30 Vaccine

Neutralizing activity of vaccine-induced antibodies to two Bacillus anthracis toxin components, lethal factor and edema factor
From Jan Clin Vaccine Immunol

Edema toxin impairs anthracidal phospholipase A2 expression by alveolar macrophages
From Dec 7 PLoS Pathog

Catalytically inactive anthrax toxins(s) are potential prophylactic agents
From Dec 5 Vaccine

Pharmacokinetics-pharmacodynamics of gatifloxacin in a lethal murine Bacillus anthracis inhalation infection model
From Dec Antimcrob Agents Chemother

In vitro efficacy of new antifolates against trimethoprim-resistant Bacillus anthracis
From Dec Antimicrob Agents Chemother

Effects of endogenous D-alanine synthesis and autoinhibition of Bacillus anthracis germination on in vitro and in vivo infections
From Dec Infect Immun

Countering anthrax: vaccines and immunoglobulins
From Clin Infect Dis, published online Nov 7

Anthrax protective antigen cleavage and clearance from the blood of mice and rats
From Nov Infect Immun

Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax
From Nov Infect Immun

Project Bioshield: actions needed to avoid repeating past problems with procuring new anthrax vaccine and managing the stockpile of licensed vaccine
GAO report released Oct 23

Anthrax vaccine and public health policy
From Nov Am J Public Health

 

Provided by the Center for Infectious Disease Research and Policy (CIDRAP), University of Minnesota.


Sponsored through an educational grant from BD

 

APIC does not endorse or recommend the products or services of any commercial entity.
Association for Professionals in Infection Control and Epidemiology, Inc. 
1275 K St., NW, Suite 1000, Washington, DC, 20005-4006 (p) 202.789.1890 (f) 202.789.1899
apicinfo@apic.org |  Privacy Policy   |  Terms of Use